IL6 and cancer: Given this strong relationship between inflammation and cancers, chronic inflammatory markers are sometimes used as a predictor and assessment tool to determine cancer status, such as interleukin (IL)-6 and tumor necrosis factor-a (TNF-α), in hepatocellular carcinoma recurrence [6].